XML 53 R43.htm IDEA: XBRL DOCUMENT v3.25.3
Collaboration Agreements - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Revenue from collaboration   $ 7,543,000 $ 61,000 $ 15,779,000 $ 1,710,000  
Short-term deferred revenue   0   0   $ 6,221,000
Long-term deferred revenue   54,204,000   54,204,000   $ 54,204,000
Bristol Myers Squibb Company ("BMS") | Amended Collaboration Agreement 2019            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Agreement extension period, options to extend 2 years          
Revenue from collaboration   7,500,000 $ 0      
Short-term deferred revenue   0   0    
Long-term deferred revenue   $ 50,200,000   $ 50,200,000